Shanghai Shyndec Pharmaceutical Co.,Ltd.’s Net Profit Rose 101.5% in First Quarter of 2023

Shanghai Shyndec Pharmaceutical Co.,Ltd. (上海现代制药股份有限公司) (600420.SH) reported a net profit of 274.3 million yuan in the first quarter of 2023, up 101.5% year-on-year.

Meanwhile, the company posted 3.4 billion yuan in revenue, up 5.3% year-on-year.

At the end of the reporting period, it had 19 billion yuan in total assets and 6.5 billion yuan in total liabilities, with a liability-to-asset ratio of 34.5%.